Systematic Review
Accepted on 23 Oct 2025
Long-term Outcomes of PD-1 Inhibitors Plus Chemotherapy as First-Line Treatment for Advanced HER2-negative Gastric Cancer: An updated Systematic Review and Meta-Analysis
in Cancer Immunity and Immunotherapy